Search results with tag "Daratumumab"
REFERENTIEL DE TRAITEMENT DU MYELOME MULTIPLE
www.onco-occitanie.frDaratumumab Dexamethasone Daratumumab Velcade Dexamethasone (DVD) Daratumumab Revlimid Dexamethasone (DRD) Référentiel régional Myélome Référentiel thérapeutique Page 18 sur 27 Bendamustine Thalidomide Prednisone (BTP) 2 2: ...
Procedures, programs and drugs that require precertification
www.aetna.comFor the following services, providers call 1-866-752-7021 for precertification and fax applicable request ... Specialty Medication Request Form located online under ... (daratumumab, J9145) Darzalex Faspro (daratumumab and . care —
Patient Assistance Program Application - JJPAF
jjpaf.org(daratumumab) Injection for intravenous infusion. DARZALEX . FASPRO ® (daratumumab and hyaluronidase-fihj), Injection for ... treatment, care management, health insurance and benefits, medication history, and prescriptions (collectively, “Health Information”), whether in written or verbal form, including portions of my medical record. ...
Darzalex™ (daratumumab) Medication …
www.aetna.comDarzalex TM (daratumumab) Medication Precertification Request Page 2 of 2 (All fields must be completed and return both pages for precertification review)
达雷妥尤单抗注射液说明书
www.xian-janssen.com.cn英文名称：Daratumumab Injection 汉语拼音：Daleituoyou Dankang Zhusheye 【成份】 主要成份：达雷妥尤单抗。 辅料：冰醋酸、甘露醇、聚山梨酯20、三水乙酸钠、氯化钠、注射用水。 【性状】 为无色至淡黄色的浓缩注射液。 【适应症】
Hypersensitivity & Infusion Reaction Management
intranet.stephensoncancercenter.orgFeb 21, 2019 · These is common with taxanes, rituximab, bleomycin, daratumumab, PEGylated liposomal doxorubicin and daunorubicin, trastuzumab, immunotherapy (list), brentuximab, ofatumumab, panitumumab. Related to the administration of the chemotherapy, the agent may or may not have an allergic ... Concomitant medication
Procedures, programs and drugs that require …
www.aetna.com(daratumumab and hyaluronidase-fihj) Dupixent* (dupilumab) Empliciti (elotuzumab) Enzyme replacement drugs: Aldurazyme (laronidase) —precertification for the drug and site of care required Brineura (cerliponase alfa) Cerezyme (imiglucerase) —precertification for the drug and site of care required. Elaprase (idursulfase) — precertification
Blue Cross and BCN utilization management medical drug …
www.bcbsm.comThese pr ograms help ensure that patients receive medication that is medically necessary and appropriate for their situations. For most medical benefit drugs . Submit prior authorization requests through the . ... daratumumab-hyaluronidase-fihj . PPO .
HIGHLIGHTS OF PRESCRIBING INFORMATION These …
www.pi.amgen.como Daratumumab and hyaluronidase-fihj and dexamethasone. • Kyprolis is indicated as a single agent for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
For Health Professionals Who Care For Cancer …
www.bccancer.bc.caFor Health Professionals Who Care For Cancer Patients . Inside This Issue: Cancer Drug Manual –New: Daratumumab
Daratumumab, bortezomib & dexamethasone (DVd)
www.swagcanceralliance.nhs.ukSubcutaneous daratumumab Administer via sub-cutaneous injection over 5 minutes. Patients should be observed for at least 6 hours after the end of the SC injection following the first dose (or as per local policy) and, if deemed necessary, after subsequent injections. Pre-medication 1-3 hours prior to daratumumab infusion (or subcutaneous ...
Similar queries
Daratumumab, Precertification, Request, Medication Request, Assistance, Medication, Daratumumab) Medication, Daratumumab) Medication Precertification Request, Procedures, programs and drugs that require, And BCN utilization management medical drug, PRESCRIBING INFORMATION, Health Professionals Who Care For Cancer